1 Min Read
Feb 7 (Reuters) - Jubilant Life Sciences Ltd :
* Approved acquisition of optionally convertible redeemable preference shares of Jubilant Biosys aggregating to 1.87 billion rupees Source text: bit.ly/2kIuKId Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.